# Two Bear Capital — Full Reference

> Detailed reference for AI assistants. Includes firm overview, portfolio company descriptions, and team member bios.

## About Two Bear Capital

Two Bear Capital invests in founders with breakthrough ideas to solve urgent, complex problems by harnessing life sciences and technology. The firm was founded in 2019 by Mike Goguen, combining two decades of top-decile venture capital experience with deep domain expertise in technology and life sciences. Two Bear has offices in Menlo Park, San Diego, Boston, and New York, with a home base in Whitefish, Montana.

## Portfolio Companies

### Abilita Therapeutics
URL: https://www.twobearcapital.com/portfolio/abilita-therapeutics/
Website: https://abilitatx.com/

Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets.

Abilita Therapeutics is a biotech company specializing in discovering and developing therapies for the most challenging membrane proteins, including GPCRs, ion channels and transporters. Despite their high significance, hundreds of such drug targets remain untapped. Abilita's unique strength lies in generating transformative, whole-protein antigens through the Enabled Membrane Proteins (EMP™) platform, a proprietary directed evolution approach that swiftly creates enhanced target variants, which allow the discovery of novel medicines. The company's proven technology is backed by numerous collaborations with top pharma and biotech partners. After honing internal antibody discovery skills to complement the EMP™ system, Abilita is actively building a large pipeline of internal assets, and will foster comprehensive research partnerships from target validation to development candidate stages.

### Arch Systems
URL: https://www.twobearcapital.com/portfolio/arch-systems/
Website: https://archsys.io/

Arch empowers manufacturers with expert, prebuilt data tools to solve problems faster and improve operations at every level of the organization.

Arch® provides manufacturers with a comprehensive understanding of their operational landscape, empowering the entire organization to make informed decisions, increase ROI, and drive lasting improvements centered around common goals. Arch has built the largest collaboration of industry domain experts working hand-in-hand with data scientists to constantly map new signals in the data, adding them to the ever-growing library of operational analytics and recommendations. These signals and recommendations change how manufacturers tackle their most complex problems and create a holistic view that guides them to meaningful, actionable intelligence. Arch is a recipient of the 2022 Global Technology and Mexico Technology Awards, and a 2023 Manufacturing Leadership Council Award. The ArchFX Platform provides the machine connectivity, data management, and advanced insights needed to achieve digital transformation across the manufacturing organization.

Open Roles (3):
- Technical Account Manager — Mid–Senior, On-site, Palo Alto, CA, USA — https://arch-systems.breezy.hr/p/0fccfc988b80-technical-account-manager
- Manager, Level 2 Technical Support — Director, On-site, Kuala Lumpur, Malaysia — https://arch-systems.breezy.hr/p/fcfce3c2e00e-manager-level-2-technical-support
- Staff Platform Engineer (U.S.-based required) — On-site, Palo Alto, CA, USA — https://arch-systems.breezy.hr/p/a5082204b5c7-staff-platform-engineer-u-s-based-required

### Binarly
URL: https://www.twobearcapital.com/portfolio/binarly/
Website: https://www.binarly.io/

Binarly detects and helps remediate known and unknown vulnerabilities at every step of the device and software supply chain.

Binarly is a global firmware and software supply chain security company founded in 2021. The company’s flagship Binarly Transparency Platform is an enterprise-class, AI-powered solution used by device manufacturers, OEMs, IBVs and product security teams to identify known and unknown vulnerabilities, misconfigurations and signs of malicious code implantation. Binarly’s validated remediation playbooks have significantly reduced the cost and time to respond to security exposures. Based in Los Angeles, California, Binarly brings decades of research and program analysis expertise to build solutions to protect businesses, critical infrastructure, and consumers around the world. Binarly is backed by Two Bear Capital, Blu Ventures, Canaan Partners, Cisco Investments, Liquid2, Westwave Capital and Acrobator Ventures.

### CIQ
URL: https://www.twobearcapital.com/portfolio/ciq/
Website: https://ciq.com/

Do the impossible with CIQ’s secure, reliable, and open infrastructure solutions.

CIQ builds secure, reliable, and open infrastructure solutions at scale, with dedicated world-class support for a range of performance-intensive computing and enterprise technologies. From the base operating system, through containers, orchestration, provisioning, computing and up to cloud applications, CIQ works with every part of the technology stack enabling organizations to focus on their core competencies, driving business-transforming innovation. CIQ is the founding support and services partner of Rocky Linux and the creator of the next-generation federated computing stack.

Open Roles (7):
- Sales Development Rep - North America (Must be located in India) — Entry level, Remote — https://boards.greenhouse.io/ciq/jobs/5365253008
- Regional Sales Director - West Coast — Director, Remote — https://boards.greenhouse.io/ciq/jobs/5363349008
- Account Executive (West Coast Preferred) — Mid–Senior, Remote — https://boards.greenhouse.io/ciq/jobs/5362030008
- Principal Software Engineer - GoLang — Remote — https://boards.greenhouse.io/ciq/jobs/5217645008
- Principal Linux Engineer — Remote — https://boards.greenhouse.io/ciq/jobs/5282342008
- Linux Kernel Development Engineer — Mid–Senior, Remote — https://boards.greenhouse.io/ciq/jobs/5287900008
- Sr./Principal Performance Engineer — Remote — https://boards.greenhouse.io/ciq/jobs/5209698008

### Conceal
URL: https://www.twobearcapital.com/portfolio/conceal/
Website: https://conceal.io/

A pioneer in browser-native Security Service Edge (SSE) and proxy-less Zero Trust Network Access (ZTNA) technology.

Conceal delivers a Browser-Native Security Service Edge (SSE) platform that provides Zero Trust Access and in-browser security without relying on VPNs, proxies, or datacenter-routed traffic. Conceal enables secure, direct access to any application from any device, helping organizations reduce complexity, cost, and risk. Security and IT teams gain complete visibility into user activity and threats, with pre-built integrations that stream data into SIEM/XDR platforms and commonly used tools such as Splunk, SOAR, and BI solutions. Conceal also provides executive-level reports showing the platform’s measurable value and risk reduction. Conceal is backed by investors like Two Bear Capital, Allegis Cyber and Gula Tech Adventures.

### Dymium
URL: https://www.twobearcapital.com/portfolio/dymium/
Website: https://www.dymium.io/

A data access management company that enables organizations to bring “data access to where data lives.”

Dymium enables customers to access the data required, in the right context and format, in real-time, without the burden of managing yet another data environment or putting your company or country at risk. Dymium enables organizations to securely and cost-effectively manage data access requirements across a proliferation of data without stifling innovation. The Dymium Platform provides data agility without risk by taking data access to where data lives. The solution eliminates the complexity, availability, and timeliness challenges of duplicating data into data warehouses or data lakes. It uniquely combines a zero trust architecture, centralized access policies, and real-time, universal data translation services, ensuring only authorized users can access the right data regardless of its location.

### Elisity
URL: https://www.twobearcapital.com/portfolio/elisity/
Website: https://www.elisity.com/

Transform network security with Elisity’s IdentityGraph™, ensuring confident policy enforcement and rapid, seamless deployment.

Elisity is a cloud-native security solution that provides frictionless, centrally managed least privilege access to protect corporate data and critical assets from malicious lateral movement across the network. Their identity-based microsegmentation technology allows organizations to quickly gain visibility into network assets and traffic flows, enabling the creation of policies to protect the most critical enterprise assets. Elisity is simple to deploy and manage, offering non-disruptive deployment, rapid time to value, and adaptability to organizations of all sizes. Elisity requires no additional hardware or network downtime, making it an ideal solution for enhancing existing access layer switching infrastructure.

Open Roles (10):
- Back End Engineer — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=39
- QA Tester / Quality Assurance Engineer — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=33
- Engineering Product Owner — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=32
- Full Stack AI Engineer — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=31
- Account Executive — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=6
- Support Engineer — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=26
- Escalation Support Engineer — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=5
- Inside Sales Representative (ISR) — Remote, United States — https://www.elisity.com/careers?job=4
- Senior Sales Engineer — Remote, United States — https://www.elisity.com/careers?job=3
- Senior Inside Sales Representative — On-site, San Jose, CA, USA — https://www.elisity.com/careers?job=2

### Fyr Bio
URL: https://www.twobearcapital.com/portfolio/fyr-bio/
Website: https://fyr.bio/

FYR Bio is transforming healthcare by developing diagnostic solutions that utilize novel insights on disease to innovate the next generation of liquid biopsies.

FYR Bio is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, trials, drugs and outcomes. FYR’s EV-Omics (EVO) platform leverages its proprietary technology, SPARCs™, to enrich for extracellular vesicles from diseased cells and enable assessment of cellular proteins and nucleic acids with just a peripheral blood sample. Utilizing AI-enabled multiomic insights, EVO unravels the complexity of disease mechanisms, thereby informing potential diagnostic and treatment options. The unparalleled view provided by FYR’s multiomic approach can transform personalized patient care, from screening through therapy selection and monitoring.

### Graphiant
URL: https://www.twobearcapital.com/portfolio/graphiant/
Website: https://www.graphiant.com/

Graphiant is a provider of next-generation network services. Graphiant Network Edge is an “as-a-Service” solution that connects enterprise resources, hybrid cloud, network edge, customers, and partners.

Enterprise networks are more complex than ever. Half of all workloads now live in the cloud. Every device needs connectivity. Workers are increasingly remote. Edge clouds are becoming common. Data is moving from the core to both the edge and cloud. And enterprises are increasingly connecting to partner and customer networks. Legacy networking solutions can’t keep up. What enterprises need is a network that combines robustness and agility. And that’s precisely what Graphiant provides. The Graphiant Network Edge is robust enough to offer guaranteed service, and because it is delivered as-a-Service, Graphiant provides unmatched agility.

Open Roles (1):
- Project Manager, Network Migration — Mid–Senior, On-site, United States — https://graphiant.bamboohr.com/careers/102

### Gravwell
URL: https://www.twobearcapital.com/portfolio/gravwell/
Website: https://www.gravwell.io/

Gravwell helps organizations detect anomalies, investigate threats, and ensure AI systems behave as intended.

Gravwell is a full-stack data analytics and security platform purpose-built for high-volume, high-fidelity machine data. By enabling organizations to ingest, index, and query logs, network traffic, and event streams at scale, Gravwell empowers security teams to rapidly investigate threats, detect anomalies, and meet compliance requirements without data silos or sampling. With a flexible ingestion engine and vendor-agnostic architecture, Gravwell delivers deep visibility across IT and OT environments, arming defenders with the speed and context needed to outpace modern adversaries. Gravwell investors include Two Bear Capital, Gula Tech Adventures, Innosphere Ventures Fund, Next Frontier Capital, Kickstart, and Rise of the Rest.

Open Roles (1):
- Sales Engineer — Mid–Senior, Remote, United States — https://boards.greenhouse.io/gravwell/jobs/4163853009

### Inimmune
URL: https://www.twobearcapital.com/portfolio/inimmune/
Website: https://inimmune.com/

Inimmune is a leading vaccine adjuvant and immunotherapy company utilizing the human immune system to prevent and treat disease.

Inimmune is a clinical-stage immunotherapy biotech company with a deep pipeline of vaccine adjuvants and immunotherapeutics advancing potential breakthroughs in human health. With a full suite of state-of-the-art preclinical labs and an extensive network of collaborations with top-tier researchers across the country, Inimmune has a growing pipeline of disruptive technologies and the capability to advance these from early discovery to clinical use. The leading R&D team’s performance has been validated with the awarding of several large National Institute of Health contracts and grants which directly contribute to the advancement of novel adjuvants and immunotherapies. Inimmune’s disease-modifying treatments are expected to make major impacts in the allergy, cancer and vaccine fields in the years to come for the betterment of humankind.

### Leapfrog Bio
URL: https://www.twobearcapital.com/portfolio/leapfrog-bio/
Website: https://www.leapfrog.bio/

Leapfrog Bio — accelerating precision oncology, expanding treatment and improving outcomes.

Leapfrog Bio is taking a different approach to precision medicine and the treatment of cancer. Traditional approaches to developing cancer therapeutics focus on modifying the underlying disease-causing biology. This approach typically leads to an uncertain and years-long path of drug discovery, as well as the risks of unknown potential side effects once in the clinic. Leapfrog’s strategy leverages the company’s Precision PGx Platform™ to evaluate existing, clinically researched cancer small molecules to identify sensitizing mutations that result in cancer cell death. By using existing small molecules with well-described safety profiles, Leapfrog can move quickly into the clinical setting and reduce the risk, time, and cost of drug discovery.

### Montara Therapeutics
URL: https://www.twobearcapital.com/portfolio/montara-therapeutics/
Website: https://montaratx.com/

Montara develops safe and efficacious therapies to improve the lives of patients with neurological diseases.

Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara’s BrainOnly platform allows brain-specific pharmacology utilizing existing and novel chemical warheads, restricting deleterious on-target off-tissue peripheral activity. BrainOnly holds the potential to drug numerous targets previously considered undruggable. The company is backed by top-tier investors, including Two Bear Capital, SV Health Investors’ Dementia Discovery Fund, KdT Ventures, and Dolby Family Ventures.

### Novoron
URL: https://www.twobearcapital.com/portfolio/novoron/
Website: https://novoron.com/

Novoron Bioscience is pioneering lipoprotein-receptor drug development to repair degeneration of the central nervous system.

Novoron Bioscience develops novel therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Novoron’s unique focus on lipoprotein-receptors (LRP) enables hope for treatment of conditions for which no current therapies exist. Led by the pioneering work of Founder and CEO, Dr. Travis Stiles, the San Diego-based company is currently advancing multiple therapeutics that treat pathologies of the CNS, including multiple sclerosis, spinal cord injuries, and tauopathies such as Alzheimer’s disease. Novoron has been awarded more than $3.5 million in grant funding from the National Institutes of Health for scientific research into these conditions. Beyond the CNS, Novoron’s proprietary LRP-focused drug development platform will facilitate the future development of treatments for other intractable diseases and conditions.

### PulseData
URL: https://www.twobearcapital.com/portfolio/pulsedata/
Website: https://pulsedata.io/

PulseData provides data driven, clinically validated, predictive insights delivered right at the point of care.

PulseData leverages large, diverse datasets and extensive clinical expertise to effectively identify patients with chronic conditions. Using cutting-edge machine learning and AI models, PulseData enables early intervention, equipping healthcare teams with informed, data-driven insights precisely when they matter most – at the point of care. PulseData’s collaboration with clients ensures optimal model performance, reduces bias, and improves model explainability. The resulting actionable insights can be viewed on the platform and seamlessly integrated into clinical workflows, to enhance care management. PulseData’s strategic integration of technology and healthcare empowers providers to make well-informed decisions, which improve patient outcomes, reduce costs, and improve program performance.

### QuSecure
URL: https://www.twobearcapital.com/portfolio/qusecure/
Website: https://www.qusecure.com/

QuSecure’s QuProtect addresses today’s and future quantum, AI, and classical threats to encryption.

QuSecure is a leader in quantum-safe cybersecurity with a mission to use the advent of quantum computing to act as a catalyst to fix the foundation of data security infrastructure. The QuProtect platform requires no quantum technologies to defend against quantum, AI, and classical threats to encryption. It can be purchased through the AWS Marketplace or direct outreach to QuSecure, Accenture, Dell, Cisco, or Carahsoft. QuSecure is proud to have more successful post-quantum cryptography deployments than any other organization in the world, and the technology is currently deployed with government, banking, telecommunications, and infrastructure customers across the globe. QuSecure's quantum-resilient and crypto-agile solutions provide an easy transition path to quantum resiliency anytime, anywhere, on any device, and across any organization.

### Rainfall Health
URL: https://www.twobearcapital.com/portfolio/rainfall-health/
Website: https://www.rainfallhealth.com/

Rainfall Health helps hospitals quantify, capture, and maximize CMS’s mandated TEAM incentives.

Rainfall Health is an AI-driven compliance and reimbursement platform that helps hospitals and medical groups navigate new value-based care models such as CMS's TEAM model, ensuring they deliver on vital case management and care delivery goals. The company is shaping a new national standard for mandated care-model compliance through the RAIN Compliant™ designation — a verifiable, AI-enabled framework adopted by hospitals, payers, and clinical partners impacted by the January 1, 2026 TEAM launch. Rainfall works with health system executives, physician groups, and post-acute partners to automate complex regulatory requirements, improve care-quality performance, and unlock new Medicare revenue streams.

Open Roles (4):
- Customer Success Manager — Mid–Senior, On-site, San Francisco, CA, USA — https://jobs.ashbyhq.com/rainfallhealth/ea04b179-27d1-469d-942b-c585fc06c5bf?embed=js
- Sales Partnerships Manager — Mid–Senior, On-site, San Francisco, CA, USA — https://jobs.ashbyhq.com/rainfallhealth/81225d1f-5054-45ca-aade-5145a5ae001b?embed=js
- Senior Software Engineer — On-site, San Francisco, CA, USA — https://jobs.ashbyhq.com/rainfallhealth/e8e01884-1a38-4207-b1f1-919e62f45c71?embed=js
- Director of Business Development — Director, On-site, San Francisco, CA, USA — https://jobs.ashbyhq.com/rainfallhealth/83dd1123-1c46-44b0-b20e-1b6cf15f491d?embed=js

### Revenium
URL: https://www.twobearcapital.com/portfolio/revenium/
Website: https://www.revenium.ai/

Revenium turns AI usage into ROI clarity — cutting costs, boosting margins, and giving leaders real-time visibility across models and agents.

Revenium gives Engineering, FinOps, DevOps, and Product teams full visibility into AI spend and performance — tracing every call, token, and agent action to help optimize usage. It is the world’s first AI economics system of record, delivering real-time visibility into the cost, performance, and ROI of AI operations. By connecting every model, agent, and transaction to its true economic footprint, Revenium empowers organizations to optimize margins, manage risk, and scale AI responsibly. Built for the era of intelligent automation, Revenium provides the financial layer that ensures AI innovation drives measurable, sustainable business value.

### Sanavia Oncology
URL: https://www.twobearcapital.com/portfolio/sanavia-oncology/
Website: https://www.sanavia.bio/

Sanavia is redefining the possibilities in the fight against cancer by harnessing scientific research and breakthrough technologies.

Sanavia Oncology believes that every cancer patient deserves a cure. Today, the majority of cancer patients do not benefit from current therapies due to drug resistance. So Sanavia is working to access the biology that will provide the understanding needed to develop novel immunotherapies that can safely and effectively overcome drug resistance and improve patients’ lives. Sanavia uses a proprietary platform to discover unexplored, clinically relevant, cancer-specific epitopes in different types of drug resistant tumors and to generate antibodies with atomic-level specificity to these epitopes. Sanavia’s process combines high throughput sequencing, single-molecule super-resolution microscopy, 3D protein modeling, and artificial intelligence. The platform enables Sanavia to replicate cancer biology ex-vivo with unprecedented accuracy, unlocking novel therapeutic targets at scale.

### Selector
URL: https://www.twobearcapital.com/portfolio/selector/
Website: https://www.selector.ai/

Selector is the industry-leading AIOps platform designed to provide instant, real-time actionable insights for managing multi-domain network and application infrastructures.

Selector empowers network, cloud, and application operators with data-centric multi-domain analytics, driving the transition to AI and ML-based operations intelligence. As the industry's first network-aware operations intelligence platform, Selector converges network, applications, and IT system observability across heterogeneous data sources, providing actionable insights that enable teams to troubleshoot network issues faster, avoid downtime, reduce MTTR and improve efficiency. An award-winning platform, Selector was most recently named one of the Bay Area's Best Places to Work by the San Francisco Business Times and the Silicon Valley Business Journal. Selector customers include Internet Service Providers (ISPs), media organizations, financial institutions, Cloud Service Providers (CSPs), retail and commercial businesses, among others.

### Talus Bio
URL: https://www.twobearcapital.com/portfolio/talus-bio/
Website: https://www.talus.bio/

Enabling drug discovery for previously undruggable transcription factors.

Founded in 2020 by Alex Federation, PhD, and Lindsay Pino, PhD, Talus Bio is a drug discovery and development company focused on therapeutics that target previously undruggable transcription factors. The Seattle-based company’s proprietary therapeutics discovery platform, MARMOT (Multiplexed Assays for the Rational Modulation Of Transcription Factors), integrates AI, next-gen proteomics, synthetic chemistry, and computational biology to engineer and interrogate drugs, proteins, and genomics at unprecedented scale. Talus Bio employs a growing team of more than a dozen world-leading experts in proteomics, biochemistry, computational biology, and machine learning.

### TileDB
URL: https://www.twobearcapital.com/portfolio/tiledb/
Website: https://www.tiledb.com/

TileDB is the ultimate multi-modal database that morphs to capture all complex analytic applications.

TileDB is the multimodal data platform designed for discovery. Unlike traditional cloud database management solutions, TileDB masters frontier and everyday data using unique shape-shifting arrays. In TileDB, users Organize, Structure, Collaborate on and Analyze all their data, all in one place, to accelerate AI-powered scientific breakthroughs. TileDB was spun out of MIT and Intel Labs in May 2017 and is backed by numerous world-class investors including AlleyCorp, Two Bear Capital, Nexus Venture Partners, EBRD, Intel Capital, Big Pi, Uncorrelated, Verizon Ventures, Lockheed Martin Ventures, Amgen Ventures, NTT Docomo Ventures, S Ventures, LDV Partners, and Scale Asia Ventures.

## Team

### Mark Adams, PhD
URL: https://www.twobearcapital.com/team/mark-adams/
Title: Partner
Location: New York
LinkedIn: https://www.linkedin.com/in/rmarkadams/

Mark Adams is a Partner at Two Bear Capital, where he focuses on life sciences, artificial intelligence, and cybersecurity companies. Mark was most recently COO and CTO at Adaptive Biotechnologies, a public biotechnology company in Seattle, WA. He has previously had C-Suite roles in several biotechnology companies, as well as leading a consulting practice at Booz Allen Hamilton. He has also led artificial intelligence and data science teams in finance at Bridgewater Associates and Leerink Partners. Mark holds a PhD in Molecular Biology from Baylor College of Medicine and he earned his BA in Biology and Computer Science from Oberlin College.

### Jenna Aronson, PhD
URL: https://www.twobearcapital.com/team/jenna-aronson/
Title: Principal
Location: Boston
LinkedIn: https://www.linkedin.com/in/jenna-aronson-397b1b14a/

Jenna is a Principal at Two Bear Capital where she sources, diligences, and leads investments in innovative life sciences therapeutics companies. She serves as board observer for Montara Therapeutics and Abilita Therapeutics. Prior to joining TBC, she was a researcher in the Genetics & Aging research unit of the MassGeneral Institute for Neurodegenerative Disease at Massachusetts General Hospital/Harvard Medical School, working under Dr. Rudy Tanzi developing 3D human neural stem cell models of Alzheimer's disease. She completed her PhD in the Brain & Cognitive Sciences Department at MIT, advised by Dr. Ed Boyden in The McGovern Institute for Brain Research, developing biotechnology platforms for enhanced resolution into clinical samples including brain tissue and liquid biopsies with applications in cancer and neurodegeneration. Her doctoral training was supported by fellowships from the Singleton Foundation and Center for Neurobiological Engineering as well as a Koch Frontiers Award and she served on the teaching team at MIT Sloan School of Management. In her free time, Jenna continues to support MIT entrepreneurs as a Sandbox Innovation Fund Mentor.

### Amalia Colangelo, PhD
URL: https://www.twobearcapital.com/team/amalia-colangelo/
Title: Principal
Location: Menlo Park
LinkedIn: https://www.linkedin.com/in/amaliacolangelo/

Amalia is a Principal at Two Bear Capital, where she leads investments in drug discovery platforms. Before joining the firm, she was a management consultant advising global clients on R&D strategy, antibody-drug conjugate M&A deals, and VC diligence for emerging therapeutics. She has also worked at two life science venture funds, sourcing and evaluating therapeutic and diagnostic investment opportunities. Amalia earned her PhD in Biological and Biomedical Sciences from Harvard University under Dr. Jason Buenrostro in the Department of Stem Cell and Regenerative Biology. Her doctoral research focused on applying single cell genomics and high-throughput imaging technologies to uncover links between epigenetic regulation, cell fate plasticity, and mechanical stress responses. Passionate about global health, Amalia co-founded MyBelle, an NGO dedicated to reducing maternal mortality in Nigeria through mobile clinics, informational seminars, and a maternal-health app. This work led to publications evaluating the World Health Organization’s calcium intake guidelines, highlighting the impact of calcium deficiency on maternal health, and pregnancy-related hypertension.

### Mike Goguen
URL: https://www.twobearcapital.com/team/mike-goguen/
Title: Founder & Managing Partner
Location: Whitefish
LinkedIn: https://www.linkedin.com/in/michael-goguen-23314/

Two Bear Capital is led by Mike Goguen, a 20-year veteran of Sequoia Capital. Between 1996 and 2016, Mike sponsored 54 investments with a combined market value of over $67B. He led investments across sectors including cybersecurity, bioinformatics, biopharma, networking, and semiconductors. Mike has built the Two Bear brand in Montana as an active philanthropist and as a first responder with Two Bear Air, which completed more than 600 helicopter search and rescue missions in the region. Two Bear Capital is the result of Mike’s passion to combine the life-changing platforms that venture capital can enable with a desire to make lives better in an enduring way. Mike did his undergraduate studies at Cornell and received his MS in Electrical Engineering from Stanford.

### Cris Neckar
URL: https://www.twobearcapital.com/team/cris-neckar/
Title: Partner
Location: Menlo Park & Whitefish
LinkedIn: https://www.linkedin.com/in/crisneckar/

A seasoned veteran of the information security industry, Cris Neckar has over 17 years of leadership experience ranging from software engineering to penetration testing and digital forensics. Prior to joining Two Bear Capital, Cris held leadership roles at a variety of startups including co-founding Divergent Security, a top-tier offensive security assessment service provider. Previously, Cris was among the original members of Google's Chrome Security Team, managing the security of the Chrome web browser and developing state-of-the-art advancements in software security and end-user defense. Prior to his work at Google, Cris led the application security practice for Neohapsis (now Cisco Systems). As a security researcher, Cris has discovered, and responsibly disclosed, critical vulnerabilities in software infrastructure ranging from Microsoft Windows to Cisco WebEx, and has been instrumental in the investigations of both high-profile data breaches and nation-state intelligence campaigns. Cris also served as a curriculum advisory board member and professor for DePaul University's cybersecurity graduate school program.

### Lavinia Platerink
URL: https://www.twobearcapital.com/team/lavinia-platerink/
Title: Associate
Location: Menlo Park
LinkedIn: https://www.linkedin.com/in/lavinia-van-hamel-platerink-017535204/

Lavinia (“Livvy”) is an Associate on the Investment Team at Two Bear Capital, where she sources investment opportunities and supports diligence on new and existing investments with a focus on artificial intelligence, quantum computing, and cybersecurity technologies. Previously, she served as a Research Analyst at the firm. Before joining Two Bear, she spent two summers at S32; her market research on vertical AI in fintech and logistics shaped two of the firm’s investments, including Puzzle Financial’s Series A. In previous data analyst roles, Livvy developed cloud-cost-optimization algorithms at Unity Technologies and parsed ATLAS collision data at CERN in partnership with the Lawrence Berkeley National Laboratory—experiences that anchor her evidence-driven approach to evaluating emerging tech. Earlier, she engineered suspension geometry for UC Berkeley’s Formula Electric team, competing in the 2022 SAE Electric Vehicle event. Livvy holds a BA in Applied Mathematics, with a minor in Physics.

### Avery Sonnenberg, PhD
URL: https://www.twobearcapital.com/team/avery-sonnenberg/
Title: Partner
Location: Whitefish
LinkedIn: https://www.linkedin.com/in/averysonnenberg/

Avery Sonnenberg, PhD is a Partner at Two Bear Capital based at the firm’s headquarters in Whitefish, Montana. Avery focuses on technological advancements that can lead to transformative outcomes in therapeutics, diagnostics, life science tools and medical devices, particularly in oncology and neurodegeneration. Previously, he was part of the Life Science Innovation group at Becton Dickinson where he helped drive innovation and strategic growth in alignment with emerging market and technology trends. He maintains a relentless curiosity about the potential for impactful technology as well as a deep commitment to fostering meaningful relationships with portfolio company founders. Avery holds a PhD in Bioengineering from University of California, San Diego and an MS in Electrical Engineering from Rochester Institute of Technology.

### J. Seth Strattan, PhD
URL: https://www.twobearcapital.com/team/j-seth-strattan/
Title: General Partner
Location: Menlo Park
LinkedIn: https://www.linkedin.com/in/jseth/

J. Seth Strattan, PhD is a General Partner based in Menlo Park focused on the application of data science, software engineering, and genomics technologies to problems in medicine and biology. Seth joined Two Bear Capital from Stanford University where he built and led engineering and data science teams in the Encyclopedia of DNA Elements (ENCODE), Human Cell Atlas (HCA), and International Human Epigenomics (IHEC) consortia. Previously, he held entrepreneurial and management positions in enterprise software and consulting. Seth brings to Two Bear Capital a passion for empowering collaborations between scientists and engineers to deliver durable, reproducible solutions to problems in genomics and health. Seth earned his PhD in Structural Biology and BA in Philosophy from Stanford University.

### John Sullivan
URL: https://www.twobearcapital.com/team/john-sullivan/
Title: Venture Partner
Location: Boston
LinkedIn: https://www.linkedin.com/in/john-l-sullivan-74a19314/

John is a Boston-based Venture Partner at Two Bear Capital. He has over 25 years of experience analyzing healthcare and life sciences industry trends, as well as emerging biopharma company assets and strategies. John was the Director of Research for the investment bank Leerink Partners, where he was also the firm’s Healthcare Investment Strategist. Prior to that, John was an award-winning Wall Street research analyst in life sciences and biotechnology. John is a graduate of Boston University and current member of the Dean’s Advisory Board of the School of Public Health. He holds graduate degrees from both Northwestern University’s Kellogg School of Management and Harvard University.

### Neil White
URL: https://www.twobearcapital.com/team/neil-white/
Title: Partner
Location: Silicon Valley
LinkedIn: https://www.linkedin.com/in/neilandrewwhite/

Neil has over 15 years of experience in the life sciences sector, spanning investment banking and leadership roles. Previously, he worked in Capital Markets at Bank of America Merrill Lynch, and in Healthcare Mergers & Acquisitions advisory at Torreya Partners and Perella Weinberg Partners. He was most recently a senior advisor to the Health Team of Emerson Collective, now Yosemite, focused on investing in and supporting the clinical translation of novel treatments in oncology and improving the lives of cancer patients. Neil received his MS from the University of Oxford and BS with honors from the University of Toronto.

### Kristen Getchell, PhD
URL: https://www.twobearcapital.com/team/kristen-getchell/
Title: Partner, Head of Platform
Location: Boston
LinkedIn: https://www.linkedin.com/in/kristen-getchell-88b93555/

Kristen Getchell is Head of Platform, Partner at Two Bear Capital. In this role, she develops and manages post-investment portfolio support, helps foster founder and operator relationships, and leads strategic programs that drive value across the portfolio. Kristen is the Karani Term Chair and a professor of business communication at Babson College and a certified executive coach. She is an award-winning teacher and scholar with experience building high-impact communication programs, scaling founder and operator support, and leading portfolio-wide initiatives in venture capital and higher education. Her areas of expertise include facilitating cross-functional collaboration and driving measurable outcomes through storytelling, coaching, and systems design. Kristen earned a PhD from Indiana University of Pennsylvania, an MA from Dartmouth College, and a BA from the University of Connecticut.

### Nikki Johns
URL: https://www.twobearcapital.com/team/nikki-johns/
Title: VP, Talent Acquisition
Location: Whitefish
LinkedIn: https://www.linkedin.com/in/nikki-johns/

Nikki Johns is the Vice President of Talent Acquisition at Two Bear Capital. She has more than 15 years of experience leading and growing teams globally within the strategy, technology, and healthcare spaces. During the course of her career, she has held positions at KPMG, PwC, and FTI Consulting where she ran large platforms, large global teams, and led new initiatives in life sciences. She has been responsible for thousands of hires spanning from associate to partner level and C-suite roles, building new initiatives from scratch, and helping to turn around high-risk investments by recruiting the right talent for the jobs. She graduated from Indiana University with a BA in Psychology. She currently resides in Whitefish, Montana.

### Jeff Miller
URL: https://www.twobearcapital.com/team/jeff-miller/
Title: Operating Partner, Enterprise
Location: New York
LinkedIn: https://www.linkedin.com/in/jeff-miller-0697ab6/

Jeff Miller is an Operating Partner at Two Bear Capital. He works with Two Bear’s enterprise portfolio companies, helping them create efficient infrastructures and implement world-class sales strategies. Prior to joining Two Bear Capital, Jeff served as the Chief Revenue Officer at companies including StarTree and Cockroach Labs. At Cockroach Labs, Jeff led sales from 0 to over $80 million in ARR, driving the company valuation to $5 billion in less than four years for their Series E. During the course of his career, Jeff has also held Senior Vice President of Sales positions at Hortonworks, Virtustream, VMware, Novell, and JBoss. As Senior Vice President of Sales at Hortonworks, he drove sales from 0 to > $250 million in ARR in record time, powering a successful IPO and a subsequent $1.45 billion acquisition from Cloudera. As Vice President of Sales at SpringSource, he helped drive sales from $5 million ARR to $30 million in ARR. This led to a $450 million+ acquisition by VMware, where he stayed to lead the revenue to over $100 million in ARR post-acquisition within a year. Jeff earned his BA in Business from Clemson University, where he was a four-year starter on the baseball team.

### Zander Mykytiuk
URL: https://www.twobearcapital.com/team/zander-mykytiuk/
Title: Operating Associate
Location: New York
LinkedIn: https://www.linkedin.com/in/zandermykytiuk/

Zander is a Senior Analyst at Two Bear Capital. He focuses on supporting research and diligence efforts across potential new investments as well as current portfolio companies. Prior to Two Bear, Zander was a management consultant, entrepreneur, biotech business development lead, and healthcare venture fellow with Alley Corp. He started his career as a management consultant at ClearView Healthcare Partners, a firm that provides strategic consultation to healthcare and life sciences companies and investors. After ClearView, Zander founded his own boutique consulting firm, Blair Biosciences Group. In 2022, Zander worked as Business Development Manager at Artizan Biosciences, a pioneering precision therapeutics start-up. Zander earned his BA from Washington University in St. Louis with majors in Finance and Biology. During his undergraduate studies, Zander was a researcher in the Klechevsky Lab, where he studied the roles and mechanisms by which dendritic cells modulate in the immune system.

### Tim Veil
URL: https://www.twobearcapital.com/team/tim-veil/
Title: Chief Information Officer
Location: New York
LinkedIn: https://www.linkedin.com/in/timveil/

Tim Veil is the Chief Information Officer at Two Bear Capital, where he leads the firm’s artificial intelligence, data and analytics strategy across investing, portfolio support and internal operations. He partners with deal teams and portfolio companies to apply AI and data-driven insights that sharpen sourcing, diligence and value creation, while building the technology foundation that scales Two Bear’s platform. Prior to joining Two Bear, Tim was the Vice President of Solutions Engineering and Enablement at StarTree, a real-time analytics platform. Before this, he was Head of Sales Engineering at Cockroach Labs, creator of CockroachDB – a cloud-native, distributed SQL database. During the course of his career, he has served as the Principal Solutions Engineer of OverOps, an Enterprise Account Executive and Global Account Manager with Hortonworks, Solutions Architect with GridGain Systems, and Director of Software Development of Cognia. He began his career with Ernst & Young and earned his BBA in Finance and Management Information Systems (MIS) from the University of Georgia.

### Ashley Archibeque
URL: https://www.twobearcapital.com/team/ashley-archibeque/
Title: Executive Assistant
Location: Whitefish
LinkedIn: https://www.linkedin.com/in/ashley-archibeque/

Ashley Archibeque is Executive Assistant to Two Bear Capital's Founder and Managing Partner Mike Goguen. With a focus on strategic prioritization, Ashley ensures seamless operations in the executive office, allowing Mike to concentrate on the highest-impact initiatives for the firm. Ashley has over a decade of experience supporting top-level executives across various sectors in all aspects of operations. Prior to joining Two Bear Capital, Ashley held pivotal roles in start-ups, including Chief of Staff and Executive Operations Manager at Sentral. She also worked in the financial industry for over seven years in marketing and analytics. Ashley holds a BS in Finance from Regis University in Colorado.

### Erika Bolden
URL: https://www.twobearcapital.com/team/erika-bolden/
Title: Operations Manager
Location: San Diego
LinkedIn: https://www.linkedin.com/in/erika-bolden-4a09405a/

Erika Bolden is an Operations Manager at Two Bear Capital. She administers day-to-day operations, budgets, and internal processes, working closely with leadership on planning and execution. Her background spans business management and financial operations. Collaborative and proactive, she brings a practical approach to supporting organizational needs. Erika earned her BA in Philosophy from DePaul University.

### Kevin Day
URL: https://www.twobearcapital.com/team/kevin-day/
Title: Partner, Head of Capital Formation
Location: New York
LinkedIn: https://www.linkedin.com/in/kevin-day-62804b1a/

Kevin Day is the Head of Capital Formation at Two Bear Capital. He leads the effort to find sophisticated, long-term partners to join the investor base as Two Bear continues to build a multi-decade, top-tier, high-impact venture capital firm. Prior to Two Bear, Kevin was the Head of Capital Formation at venture firm SOSV where he successfully led the fundraise of the firm’s fifth and largest fund. Kevin has deep experience working in capital development across a variety of assets classes with investors around the globe. Prior to SOSV, Kevin worked at Pluribus Labs, Systematica Investments, and BlackRock in both London and New York covering institutional clients across the U.S., Europe, Asia, Africa, and the Middle East. Kevin holds an MBA in finance from London Business School, an MBA in finance from Columbia Business School, and a BA in Political Science from the College of Charleston.

### Meagan Hennig
URL: https://www.twobearcapital.com/team/meagan-hennig/
Title: Partner, Head of Operations
Location: San Diego
LinkedIn: https://www.linkedin.com/in/meagan-hennig-a4065b4/

Meagan Hennig serves as Partner, Head of Operations at Two Bear Capital, focusing on financial management and portfolio services. Meagan began her career at Sequoia Capital and has more than a decade of experience working with early-stage companies as an investor, team member, and consultant. She is a graduate of Princeton University and earned her MS from the University of California, San Diego.

### Rachel Tsunemoto Hislop, PhD
URL: https://www.twobearcapital.com/team/rachel-tsunemoto-hislop/
Title: Principal, Director of Research
Location: San Diego
LinkedIn: https://www.linkedin.com/in/rtsunemoto/

Rachel Tsunemoto Hislop is a Principal, Director of Research at Two Bear Capital. She works in San Diego where she leads a team responsible for producing high-impact, data-driven insights to support strategic and investment decisions. Prior to joining Two Bear Capital, Rachel’s experiences in the therapeutic development process spanned from preclinical to post-approval. Most recently, Rachel was part of the medical affairs team at Acorda Therapeutics. Previously, she was a researcher on a California Institute of Regenerative Medicine grant in the laboratories of Dr. Lawrence Goldstein and Dr. Samuel Pfaff. Trained as a neuroscientist, Rachel earned her PhD from the University of California San Diego in Neuroscience where her work in the laboratory of Dr. Kristin Baldwin led to publications in Nature, Nature Neuroscience, and The EMBO Journal. She received her BS from Massachusetts Institute of Technology in Brain and Cognitive Sciences with a minor in Biomedical Engineering.

### Jennifer Howrigan
URL: https://www.twobearcapital.com/team/jennifer-howrigan/
Title: VP, Investor Relations
Location: New York
LinkedIn: https://www.linkedin.com/in/jenniferlangan/

Jennifer Howrigan is Vice President of Investor Relations at Two Bear Capital. In this role, she ensures that Two Bear Capital provides responsive, top-tier service to its existing investors. Previously, Jen worked for Warana Capital, an alternative asset manager and specialized buyer of illiquid fund investments. She was the Head of Investor Relations and Business Development for four years. Prior to Warana, Jen was a Director at Oakpoint Advisors where she was responsible for distribution as a member of the capital team. Before Oakpoint, she spent seven years in various roles at Raptor Group. During her tenure, she served as a Director of Raptor’s proprietary family office platform and as a Senior Associate of Investor Relations and Marketing. She received a BS in Administration with a concentration in Business Management from Providence College.

### Bria Iuliano
URL: https://www.twobearcapital.com/team/bria-iuliano/
Title: Executive Assistant
Location: New York
LinkedIn: https://www.linkedin.com/in/bria-iuliano/

Bria Iuliano is the Executive Assistant to the Operating Partners at Two Bear Capital. She has spent her career supporting C-suite executives and teams in growth mode. Prior to Two Bear Capital, Bria served as an Executive Assistant supporting multiple executives at Engine, Groupon, and Juniper Pharmaceuticals. At Juniper Pharmaceuticals, she worked directly with the Chief Medical Officer and clinical development and medical affairs team providing specialty administrative support including management of outside contracted vendors. Bria earned her BA in Communication and Culture from Indiana University Bloomington.

### Linda Jahn
URL: https://www.twobearcapital.com/team/linda-jahn/
Title: Executive Assistant
Location: Menlo Park
LinkedIn: https://www.linkedin.com/in/linda-jahn-a533a397/

Linda Jahn is the Executive Assistant supporting the Two Bear Capital team based in Menlo Park. She works collaboratively with both internal and external stakeholders on operational and portfolio-related initiatives. Prior to joining Two Bear Capital, Linda was an Executive Assistant at HFI Advisors and also worked for DTCP, Deutsche Telekom's venture capital arm. Before investment and asset management, Linda worked in the medical and architecture sectors.

### Liz Marchi
URL: https://www.twobearcapital.com/team/liz-marchi/
Title: Head of Community Engagement
Location: Whitefish
LinkedIn: https://www.linkedin.com/in/lizmarchi/

Liz Marchi leads Two Bear Capital’s community engagement and partnerships. She is a pioneer in building access to equity capital and high-value start-ups in nontraditional locations. She founded and led Montana-based Frontier Angels (www.frontierangels.com) for 12 years, seeding more than $20 million in very early-stage capital. Liz works to expand the broad network of investors, entrepreneurs and philanthropists who support Two Bear Capital’s mission. She is a graduate of Hollins College in Virginia, where she served as a Trustee.

### James Allison, PhD
URL: https://www.twobearcapital.com/team/james-allison/
Title: Nobel Laureate, Chair of Immunology, MD Anderson Cancer Center, University of Texas

Dr. James Allison is an American immunologist and Nobel laureate who holds the position of Professor and Chair of Immunology, and Executive Director of Immunotherapy Platform at the MD Anderson Cancer Center at the University of Texas. Dr. Allison has spent his career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.” His discoveries have led to new cancer treatments for some of the deadliest cancers. He is the Director of the Cancer Research Institute (CRI) Scientific Advisory Council. Among his many honors, Dr. Allison is a member of the National Academies of Science and Medicine and received the Lasker–DeBakey Clinical Medical Research Award in 2015. His current work seeks to improve immune checkpoint blockade therapies currently used by clinicians and identify new targets to unleash the immune system to eradicate cancer.

### Jim Caggiano
URL: https://www.twobearcapital.com/team/jim-caggiano/
Title: Chief Executive Officer, Evolve Biologics
LinkedIn: https://www.linkedin.com/in/jimcaggiano/

Jim Caggiano is the CEO of Evolve Biologics, bringing nearly 30 years of experience in the biotechnology, pharmaceutical and medical device marketplaces. Previously, he was CEO of Dendreon Pharmaceuticals LLC. Among his earlier leadership roles in the biotech, pharmaceutical and medical device industries, Jim successfully directed the divestiture of Allergan’s Lap-Band to Apollo Endosurgery in 2013. In 2015, Jim was hired by Valeant Pharmaceuticals International to run Dendreon, where he doubled the company’s enterprise value. He then developed and implemented the strategy for the 2017 sale of Dendreon to Sanpower Group for $820M. Sanpower subsequently appointed him CEO, where he led the previously bankrupt enterprise to achieve over $100 million in EBITDA in 2018 and 2019. Earlier in his career, Jim held senior roles at Allergan, Inc., Abbott Laboratories and TAP Pharmaceuticals. Jim earned a bachelor’s degree in agricultural economics (business) from Cornell University on an Army ROTC scholarship then served four years as an Armor Officer in Germany. He also holds an MBA from the Kellogg School of Management at Northwestern University.

### John Delaney, PhD
URL: https://www.twobearcapital.com/team/john-delaney/
Title: Senior Biopharmaceutical Advisor
LinkedIn: https://www.linkedin.com/in/john-delaney-4709777/

John Delaney is a Senior Biopharmaceutical Advisor. He provides counsel to an array of start-ups in the ecosystem, working closely with founders, scientists and investors. Previously, John served as Executive Director of Amgen Biologics Discovery. He was responsible for identifying large molecule therapeutic candidates in collaboration with all Amgen Therapeutic areas, including the discovery of fully human antibody therapeutics using the company’s proprietary XenoMouse platform technology. John joined Amgen in 1992 and he was based at the Amgen South San Francisco site, leading research teams in numerous Amgen locations. In 2010, John took on the site leadership role for Amgen’s Burnaby, British Columbia research facility, managing the company’s significant protein science resources in Canada, and overseeing site administration. John holds a bachelor’s degree in zoology from the University of Montana and earned his PhD in the Department of Microbiology at the University of Arizona. He completed his postdoctoral training at the University of Utah’s Department of Cellular, Viral, and Molecular Biology working on the molecular biology of chaperones and bacterial thermotolerance.

### Ellen Lubman, MBA
URL: https://www.twobearcapital.com/team/ellen-lubman/
Title: Biopharmaceutical Advisor

Ellen Lubman served as Werewolf’s Chief Business Officer from August 2020 to April 2025. From October 2018 to July 2020, Ellen served as the Chief Business Officer at Impel NeuroPharma, Inc., a publicly traded biotechnology company focused on neurological diseases. Prior to Impel, she was the Vice President of External Science & Innovation at Forest Labs, from February 2014 until its acquisition by Actavis plc in July 2014, and served in the same role at Actavis through June 2018 during which time Actavis merged with and renamed itself Allergan plc. Prior to Allergan, Ellen held numerous executive and leadership roles at Kadmon Pharmaceuticals, Bristol Myers Squibb, Celtic Pharma Management, L.P., Robertson Stephens Investment Bank and Abbott Labs. She has served on the board of directors of Reunion Neuroscience, Inc., a publicly traded biotechnology company, since June 2021 and on the board of Cytovation ASA. Ellen serves on the Advisory Board of TMRW.org and Aronora Inc. She also currently serves the board of directors of Red Door Community in NYC. Ellen earned her MBA from Stanford Graduate School of Business in Global Management.

### Bridget Martell MA, MD
URL: https://www.twobearcapital.com/team/bridget-martell-ma-md/
Title: Senior Biopharmaceutical Advisor
Location: New York
LinkedIn: https://www.linkedin.com/in/bridget-martell-7309695/

Bridget Martell MA, MD is a Senior Biopharmaceutical Advisor. Bridget has over 25 years of experience as a physician-scientist, C-suite executive, and independent board member. Throughout her career, she has moved from “bench to bedside” and contributed to the development of medicines through to regulatory approval and commercialization. As a C-suite executive, she was Chief Medical Officer of Juniper Pharmaceuticals, Kura Oncology, and RRD International, and was CEO of Artizan Biosciences. Throughout her career in pharma and biotech, Dr. Martell continued to teach at Yale University School of Medicine and was an Associate Clinical Professor for over 20 years. She currently serves as an Entrepreneur-in-Residence at Yale Ventures. She began her clinical investigation career at Yale with a career development award and was a Robert Wood Johnson Clinical Scholar. Prior to this, she served in the National Health Service Corps where she shaped a South Bronx methadone maintenance treatment program into a primary care clinic. Dr. Martell trained and was a Resident and Chief Resident at Yale New Haven Hospital in Internal Medicine. She holds a BS in Microbiology from Cornell University, an MA in Molecular Immunology from Boston University, and an MD from The Chicago Medical School.

### Joe Pinto
URL: https://www.twobearcapital.com/team/joe-pinto/
Title: Chief Customer Experience Officer, Pure Storage
LinkedIn: https://www.linkedin.com/in/joe-pinto-6853b934/

Joe Pinto is Chief Customer Experience Officer of Pure Storage. He is responsible for spearheading digital-first capabilities around automation, advanced services, and customer success while supporting Pure’s industry-leading NPS score of 81.4. Prior to joining Pure, Joe was a Senior Vice President at Cisco, where he oversaw six service businesses and the technical services team. During his 28-year tenure at Cisco, his team developed Cisco’s first technical support website and created an industry-leading solution support offer for global customers and partners. He has sponsored customers in the banking, finance and service-provider industries, helping build strong and trusted business relationships. Joe is also involved with several startups, both as an advisor and board member. He served as the Chair of the Engineering Industry Advisory Council plus was on the Tower Foundation, both at San Jose State University. He received the community partner award from SJSU in 2017. He holds a bachelor’s degree in business from Golden Gate University.

### Padmanee “Pam” Sharma, M.D., PhD
URL: https://www.twobearcapital.com/team/padmanee-sharma/
Title: Professor of Genitourinary Medical Oncology and Immunology in the Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas

Dr. Pam Sharma is an immunologist and oncologist whose research work is focused on investigating mechanisms and pathways within the immune system that facilitate tumor rejection or elicit resistance to immune checkpoint therapy. She is a professor in the departments of Genitourinary Medical Oncology and Immunology, Associate VP of Immunobiology and the T.C. and Jeanette D. Hsu Endowed Chair in Cell Biology at The University of Texas MD Anderson Cancer Center. Pam is the inaugural Scientific Director for the Immunotherapy Platform and the Director of Scientific Programs for the James P. Allison Institute at MD Anderson Cancer Center. She has written and conducted multiple innovative immunotherapy clinical trials with an emphasis on obtaining patients’ tumor samples for in-depth laboratory studies. Pam did her clinical fellowship at Memorial Sloan-Kettering Cancer Center and trained at New York Hospital, Cornell Medical Center and Pennsylvania State University. Among other honors, she was awarded the 2021 Randall Prize for Excellence in Cancer Research.